For instance, knockdown of CDK4 in the mouse model of NSCLC results in the CDK6-induced expression of mutant K-Ras [86] and CDK4/6 inhibitor treatment in breast cancer cells results in the amplification of CDK6 through a feedback mechanism [87]. This evidence concerns the gene CDK6 and non-small cell lung carcinoma.